Literature DB >> 22012915

The ErbB4 extracellular region retains a tethered-like conformation in the absence of the tether.

Ping Liu1, Samuel Bouyain, Charles Eigenbrot, Daniel J Leahy.   

Abstract

The epidermal growth factor receptor (EGFR) and its homologs ErbB3 and ErbB4 adopt a tethered conformation in the absence of ligand in which an extended hairpin loop from domain II contacts the juxtamembrane region of domain IV and tethers the domain I/II pair to the domain III/IV pair. By burying the hairpin loop, which is required for formation of active receptor dimers, the tether contact was thought to prevent constitutive activation of EGFR and its homologs. Amino-acid substitutions at key sites within the tether contact region fail to result in constitutively active receptors however. We report here the 2.5 Å crystal structure of the N-terminal three extracellular domains of ErbB4, which bind ligand but lack domain IV and thus the tether contact. This ErbB4 fragment nonetheless adopts a domain arrangement very similar to the arrangement adopted in the presence of the tether suggesting that regions in addition to the tether contribute to maintaining this conformation and inactivity in the absence of the tether contact. We suggest that the tether conformation may have evolved to prevent crosstalk between different EGFR homologs and thus allow diversification of EGFR and its homologs.
Copyright © 2011 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22012915      PMCID: PMC3323790          DOI: 10.1002/pro.753

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  24 in total

Review 1.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  Structural basis for negative cooperativity in growth factor binding to an EGF receptor.

Authors:  Diego Alvarado; Daryl E Klein; Mark A Lemmon
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

3.  A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies.

Authors:  Gabriele Schaefer; Lauric Haber; Lisa M Crocker; Steven Shia; Lily Shao; Donald Dowbenko; Klara Totpal; Anne Wong; Chingwei V Lee; Scott Stawicki; Robyn Clark; Carter Fields; Gail D Lewis Phillips; Rodney A Prell; Dimitry M Danilenko; Yvonne Franke; Jean-Philippe Stephan; Jiyoung Hwang; Yan Wu; Jenny Bostrom; Mark X Sliwkowski; Germaine Fuh; Charles Eigenbrot
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

Review 4.  EGFR family: structure physiology signalling and therapeutic targets.

Authors:  Antony W Burgess
Journal:  Growth Factors       Date:  2008-10       Impact factor: 2.511

5.  The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.

Authors:  Samuel Bouyain; Patti A Longo; Shiqing Li; Kathryn M Ferguson; Daniel J Leahy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

6.  A growing family: adding mutated Erbb4 as a novel cancer target.

Authors:  Udo Rudloff; Yardena Samuels
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

7.  A mammalian expression vector for expression and purification of secreted proteins for structural studies.

Authors:  D J Leahy; C E Dann; P Longo; B Perman; K X Ramyar
Journal:  Protein Expr Purif       Date:  2000-12       Impact factor: 1.650

Review 8.  Targeting the EGFR pathway for cancer therapy.

Authors:  James B Johnston; Sri Navaratnam; Marshall W Pitz; Jerry M Maniate; Emilia Wiechec; Heinrich Baust; Joel Gingerich; Georgios P Skliris; Leigh C Murphy; Marek Los
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 9.  Ligand-induced ErbB receptor dimerization.

Authors:  Mark A Lemmon
Journal:  Exp Cell Res       Date:  2008-10-31       Impact factor: 3.905

10.  ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor.

Authors:  Diego Alvarado; Daryl E Klein; Mark A Lemmon
Journal:  Nature       Date:  2009-08-30       Impact factor: 49.962

View more
  9 in total

1.  Rigidity of the extracellular part of HER2: Evidence from engineering subdomain interfaces and shared-helix DARPin-DARPin fusions.

Authors:  Christian Jost; Jakob C Stüber; Annemarie Honegger; Yufan Wu; Alexander Batyuk; Andreas Plückthun
Journal:  Protein Sci       Date:  2017-07-05       Impact factor: 6.725

2.  Exploring the dynamics and interaction of a full ErbB2 receptor and Trastuzumab-Fab antibody in a lipid bilayer model using Martini coarse-grained force field.

Authors:  Juan Felipe Franco-Gonzalez; Javier Ramos; Victor L Cruz; Javier Martinez-Salazar
Journal:  J Comput Aided Mol Des       Date:  2014-08-17       Impact factor: 3.686

3.  Oncogenic mutations at the EGFR ectodomain structurally converge to remove a steric hindrance on a kinase-coupled cryptic epitope.

Authors:  Laura Orellana; Amy H Thorne; Rafael Lema; Johan Gustavsson; Alison D Parisian; Adam Hospital; Tiago N Cordeiro; Pau Bernadó; Andrew M Scott; Isabelle Brun-Heath; Erik Lindahl; Webster K Cavenee; Frank B Furnari; Modesto Orozco
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-26       Impact factor: 11.205

4.  Structural evaluation of EGFR inhibition mechanisms for nanobodies/VHH domains.

Authors:  Karl R Schmitz; Atrish Bagchi; Rob C Roovers; Paul M P van Bergen en Henegouwen; Kathryn M Ferguson
Journal:  Structure       Date:  2013-06-20       Impact factor: 5.006

Review 5.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

6.  Deciphering the stepwise binding mode of HRG1β to HER3 by surface plasmon resonance and interaction map.

Authors:  Carmen Peess; Leopold von Proff; Sabine Goller; Karl Andersson; Michael Gerg; Magnus Malmqvist; Birgit Bossenmaier; Michael Schräml
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 7.  It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases.

Authors:  Tamas Kovacs; Florina Zakany; Peter Nagy
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.639

8.  Architecture and membrane interactions of the EGF receptor.

Authors:  Anton Arkhipov; Yibing Shan; Rahul Das; Nicholas F Endres; Michael P Eastwood; David E Wemmer; John Kuriyan; David E Shaw
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

9.  Ligand binding and dynamics of the monomeric epidermal growth factor receptor ectodomain.

Authors:  Hannes H Loeffler; Martyn D Winn
Journal:  Proteins       Date:  2013-08-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.